Radical cystectomy compared to intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer – is there a long-term survival difference? A Swedish nationwide analysis-Reference-Cited by-同舟云学术

Radical cystectomy compared to intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer – is there a long-term survival difference? A Swedish nationwide analysis

Published:2020-12-11 Issue:1 Volume:55 Page:46-52
ISSN:2168-1805
Container-title:Scandinavian Journal of Urology
language:en
Short-container-title:Scandinavian Journal of Urology

Author:

Wang Eugen Y-H¹²^ORCID,Larsson Ulf¹,Gårdmark Truls³,Malmström Per-Uno²

Affiliation:

1. Center for Clinical Research, Uppsala University, Sörmland, Sweden

2. Department of Surgical Sciences, Uppsala University, Nykoping, Sweden

3. Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden

Publisher

Informa UK Limited

Subject

Urology,Nephrology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21681805.2020.1851763

Reference15 articles.

1. Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study

2. Analysis of clinical characteristics, management and survival of patients with Ta T1 bladder tumours in Sweden between 1997 and 2001

3. Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe)

4. Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancer

5. Survival after radiotherapy versus radical cystectomy for primary muscle‐invasive bladder cancer: A Swedish nationwide population‐based cohort study

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy of Bacillus Calmette–Guérin instillation and radical cystectomy treatments for high-risk non-muscle-invasive urothelial cancer classified as high-grade T1 in initial and repeat transurethral resection of bladder tumor;Frontiers in Oncology;2024-06-18

2. Centralization and prospective audit of cystectomy are necessary: a commentary on the case for centralization, supported by a contemporary series utilizing the ANZUP cystectomy database;Asia-Pacific Journal of Clinical Oncology;2022-11-09

3. Improved long-term outcome of patients with non-muscle invasive, low and intermediate risk bladder cancer between 1997 and 2014; a Swedish population-based study;Scandinavian Journal of Urology;2022-05-04

4. Immune checkpoint inhibitors for BCG-resistant NMIBC: the dawn of a new era;Minerva Urology and Nephrology;2021-07

5. Patients with NMIBC with the highest risk of progression are correctly selected for cystectomy in Sweden;Scandinavian Journal of Urology;2021-01-02